Research / Stocks / DBD DBD NYSE CIK 0000028823
DIEBOLD NIXDORF, Inc · Calculating & Accounting Machines (No Electronic Computers)
COVERAGE / STANDARD
Latest filing 10-Q · Oct 28, 2026
Research state Latest filing analysis is current
Last SEC check Nov 2, 2026
Filing → research 5 min
Data basis Official SEC · no quote feed Component status Filing Evidence Research Current Official SEC filing history is available
Structured Financials Research Current Validated structured financial research is available
Filing Analysis Research Current No filing analysis job is currently running
Fundamental State Research Current Fundamental State depends on validated comparable financial metrics
RESEARCH SNAPSHOT DIEBOLD NIXDORF, Inc's latest supported as-filed period reports revenue of $994.3M . Every value below links to its SEC accession and metric lineage.
Deterministic / evidence backed Key research observations No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Profile-correct / independently verified Company quality vector Separate current dimensions—not a universal score or investment ranking.
Evidence coverage 7 / 9 General Corporate · 2026-09-30
Growth Typical
Direction Inflecting
Own history —
Peers 31th
Persistence REVERSING Margin Typical
Direction Inflecting
Own history 40th
Peers 19th
Persistence REVERSING Profitability Typical
Direction Inflecting
Own history 30th
Peers 28th
Persistence REVERSING Cash generation Pressure
Direction Deteriorating
Own history 0th
Peers 17th
Persistence EMERGING Leverage Typical
Direction Improving
Own history 20th
Peers 44th
Persistence EMERGING Capital investment Source Unavailable
Direction Unknown
Own history —
Peers —
Persistence TRANSIENT R&D investment Context Only
Direction Decreasing
Own history 0th
Peers —
Persistence EMERGING Current configuration / point in time Fundamental state A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Debt relative to revenue 20th Own-history percentile · N=10
Method Level · gp.fundamentals.debt_to_revenue
Raw value 95.47% · OPTIONAL
Operating cash generation 0th Own-history percentile · N=10
Method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -4.77% · OPTIONAL
Revenue growth RAW Current state valid · history insufficient
Method Yoy · gp.fundamentals.revenue
Raw value 5.19% · CORE
Inventory pressure 20th Own-history percentile · N=10
Method Level · gp.fundamentals.inventory_revenue_ratio
Raw value 56.49% · OPTIONAL
Gross margin 40th Own-history percentile · N=10
Method Level · gp.fundamentals.gross_margin
Raw value 24.86% · CORE
Operating margin 30th Own-history percentile · N=10
Method Level · gp.fundamentals.operating_margin
Raw value 3.90% · CORE
R&D intensity 0th Own-history percentile · N=10
Method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Deterministic multi-period research Company direction Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
As filed Sep 30, 2026 General Corporate
Capital Allocation 4 evidence-backed dimensions Balance Sheet Leverage Improving Cash Generation Deteriorating R And D Intensity Decreasing Sbc Intensity Stable [email protected] · 11 historical states · 38% confidenceCompany Direction 8 evidence-backed dimensions Balance Sheet Leverage Improving Cash Generation Deteriorating Inventory Pressure Inflecting Margin Inflecting Profitability Inflecting [email protected] · 11 historical states · 38% confidenceFinancial Quality 6 evidence-backed dimensions Balance Sheet Leverage Improving Cash Generation Deteriorating Inventory Pressure Inflecting Margin Inflecting Profitability Inflecting [email protected] · 11 historical states · 38% confidenceGovernance Evidence 4 evidence-backed dimensions Filing Amendments None Detected Auditor Changes None Detected Sbc Intensity Observed Insider Activity Observed [email protected] · 11 historical states · 50% confidenceInterpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Comparable evidence Peer context Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
Cash Generation
DBD -4.8
Peer median 13.2
Peer percentile 17th 107 valid peers · 86% coverage · -1.1 robust σ Margin
DBD 24.9
Peer median 38.6
Peer percentile 19th 104 valid peers · 84% coverage · -0.9 robust σ Sbc Intensity
DBD 0.4
Peer median 1.2
Peer percentile 13th 106 valid peers · 85% coverage · -0.7 robust σ Profitability
DBD 3.9
Peer median 9.7
Peer percentile 28th 111 valid peers · 90% coverage · -0.4 robust σ Growth
DBD 5.2
Peer median 10.2
Peer percentile 31th 108 valid peers · 87% coverage · -0.3 robust σ Inventory Pressure
DBD 56.5
Peer median 69.3
Peer percentile 35th 109 valid peers · 88% coverage · -0.3 robust σ Open group breadth → Divergence is context, not positive or negative. INSIDER STATE / 90D Recent disclosed activity
Open-market purchases 0
Sales 0
Distinct buyers 0
Repeat buyer NO Conservative Form 4 classification · not a sentiment label Flagship analysis / V3 What changed? The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Current 10-Q 0000028823-26-000040 62 governed changes · top 7 shown
Operating Leverage Deterioration Operating leverage deteriorated This cluster groups 3 independently calculated changes: Revenue increased 5.2%; Operating margin moved 391 bp lower; Operating income decreased 47.4%.
3 evidence-backed components Margin Pressure Profitability margins compressed This cluster groups 2 independently calculated changes: Gross margin moved 107 bp lower; Operating margin moved 391 bp lower.
2 evidence-backed components Operating Leverage Improvement Operating leverage improved This cluster groups 3 independently calculated changes: Revenue increased 1.7%; Operating margin moved 3 bp higher; Operating income increased 2.1%.
3 evidence-backed components Inventory Build Inventory built relative to revenue This cluster groups 2 independently calculated changes: Inventory increased 3.8%; Inventory / revenue moved 130 bp higher.
2 evidence-backed components 01
MEDIUM IMPORTANCE Margin Margin Compression 100TH HISTORICAL PCTL · N=1
Operating margin moved 391 bp lower Operating margin changed -391 basis points from the comparable as-filed period.
Why this ranks medium
Magnitude 25
Metric Family 30
Denominator Penalty 0
Historical Unusualness 0
Persistence Or Reversal 0
Significance Percent Of Revenue null
Financial Statement Significance As-filed financials Financial trajectory Each point keeps the date investors could first observe it and its accession.
As filed Current normalized · later
Capex / revenue 0.34% -10.5% ↓ Capital expenditure $3.4M +0.0% ↑ Cash & equivalents $282.4M -21.2% ↓ Debt $942.9M +0.4% ↑ Free-cash-flow proxy -$42.2M +55.2% ↑ Gross margin 24.86% -3.4% ↓ Interest expense $43.6M +65.2% ↑ Inventory $561.7M -5.7% ↓
ACTIVE TRACE Revenue DBD · as filed with the SEC · reported-date aware
Capex / revenue Q3 / 2020-09-30 0.34% -10.5% sequential point Trace ↗ Evidence inspector
Loading lineage… × Capital expenditure Q3 / 2020-09-30 $3.4M +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Cash & equivalents Q2 / 2026-06-30 $282.4M -21.2% sequential point Trace ↗ Evidence inspector
Loading lineage… × Debt Q2 / 2026-06-30 $942.9M +0.4% sequential point Trace ↗ Evidence inspector
Loading lineage… × Free-cash-flow proxy Q3 / 2020-09-30 -$42.2M +55.2% sequential point Trace ↗ Evidence inspector
Loading lineage… × Gross margin Q3 / 2026-09-30 24.86% -3.4% sequential point Trace ↗ Evidence inspector
Loading lineage… × Interest expense Q1 / 2024-03-31 $43.6M +65.2% sequential point Trace ↗ Evidence inspector
Loading lineage… × Inventory Q3 / 2026-09-30 $561.7M -5.7% sequential point Trace ↗ Evidence inspector
Loading lineage… × Net income Q3 / 2026-09-30 $6.6M -57.4% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating cash flow Q3 / 2026-09-30 -$47.4M -248.5% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating margin Q3 / 2026-09-30 3.90% -36.7% sequential point Trace ↗ Evidence inspector
Loading lineage… × Research & development Q3 / 2026-09-30 $19.8M -3.4% sequential point Trace ↗ Evidence inspector
Loading lineage… × Primary evidence Filing timeline Direct SEC links, filing dates, report periods, and amendment flags.
10-Q Oct 28, 2026 Period Sep 30, 2026 0000028823-26-000040SEC ↗ 8-K Oct 28, 2026 Period Oct 28, 2026 0000028823-26-000038SEC ↗ 4 Jul 31, 2026 Period Jul 31, 2026 0001368469-26-000010SEC ↗ 10-Q Jul 29, 2026 Period Jun 30, 2026 0000028823-26-000033SEC ↗ 8-K Jul 29, 2026 Period Jul 29, 2026 0000028823-26-000031SEC ↗ 4 Jun 30, 2026 Period Jun 26, 2026 0000929638-26-002475SEC ↗ 4 Jun 26, 2026 Period Jun 24, 2026 0000929638-26-002370SEC ↗ Form 4 Insider activity Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
“Insider purchase” rule Code P · non-derivative · acquired · direct ownership · positive price and shares · not amended
Inspectable by design
Every displayed number has a lineage. GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗